Rhodes Jason P

CIK 00015770145 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001577014

Recent Transactions

50 trades

Award
Generation Bio Co.$GBIO
Stock Option (right to buy)
2025-06-04+30,000→ 30,000 total
Award
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2025-05-30+35,000→ 35,000 total
Award
Dyne Therapeutics, Inc.$DYN
Common Stock
2025-01-27$13.50/sh+1,111,111→ 1,958,427 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-11-14$33.10/sh−72→ 847,316 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-11-14$33.10/sh−123→ 1,458,568 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-11-14$33.10/sh−583→ 5,697,508 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-11-14$33.10/sh−4→ 15,962 total
Award
Generation Bio Co.$GBIO
Stock Option (right to buy)
2024-06-06+60,000→ 60,000 total
Award
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2024-05-22+25,133→ 25,133 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-01$30.05/sh−29,435→ 1,458,691 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-01$30.05/sh−17,099→ 847,388 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-28$24.83/sh−13,109→ 864,697 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-28$25.25/sh−360→ 1,488,126 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-28$25.25/sh−210→ 864,487 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-28$24.83/sh−152,244→ 5,700,521 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-28$25.25/sh−2,430→ 5,698,091 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-28$24.83/sh−22,567→ 1,488,486 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-27$24.68/sh−3,821→ 1,511,053 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-27$24.68/sh−2,216→ 877,806 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-27$24.38/sh−23,505→ 880,022 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-27$24.38/sh−40,455→ 1,514,874 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-27$24.68/sh−25,779→ 5,852,765 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-27$24.38/sh−272,923→ 5,878,544 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-26$23.59/sh−11,736→ 909,107 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-26$23.98/sh−9,603→ 1,555,329 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-26$23.98/sh−64,783→ 6,151,467 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-26$23.59/sh−20,205→ 1,564,932 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-26$23.59/sh−136,312→ 6,216,250 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-26$23.98/sh−5,580→ 903,527 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-23$22.70/sh−159,542→ 6,352,562 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-23$22.70/sh−13,738→ 920,843 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-23$22.70/sh−23,648→ 1,585,137 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-22$22.66/sh−119,360→ 6,512,104 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-21$23.14/sh−35,164→ 6,631,464 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-21$22.44/sh−149,337→ 6,666,628 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-20$23.40/sh−3,510→ 6,815,965 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-20$22.71/sh−166,029→ 6,819,475 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-16$23.14/sh−162,707→ 6,985,504 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-15$23.88/sh−175,793→ 7,150,324 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-15$24.45/sh−2,113→ 7,148,211 total
Award
Generation Bio Co.$GBIO
Stock Option (right to buy)
2023-06-08+25,000→ 25,000 total
Award
Dyne Therapeutics, Inc.$DYN
Stock Option (right to buy)
2023-05-24+24,900→ 24,900 total
Purchase
Dyne Therapeutics, Inc.$DYN
Common Stock
2022-12-12$10.70/sh+934,581→ 934,581 total
Award
Generation Bio Co.$GBIO
Stock Option (right to buy)
2022-06-09+19,200→ 19,200 total
Award
Dyne Therapeutics, Inc.$DYN
Stock Option (right to buy)
2022-06-03+19,596→ 19,596 total
Award
Replimune Group, Inc.$REPL
Stock Option (right to buy)
2022-04-01+16,500→ 16,500 total
Award
Disc Medicine, Inc.$IRON
Stock Option (Right to Buy)
2021-10-04+17,245→ 17,245 total
Sale
Generation Bio Co.$GBIO
Common Stock
2021-09-29$24.59/sh−30→ 608 total
Sale
Generation Bio Co.$GBIO
Common Stock
2021-09-29$24.59/sh−16,556→ 0 total
Sale
Generation Bio Co.$GBIO
Common Stock
2021-09-28$25.24/sh−13,089→ 16,556 total

Companies

Recent Filings

Address

C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE

CAMBRIDGE, MA, 02139

View on SEC.gov